ITPD20040159A1 - Derivati bifunzionali del polietilenglicole loro preparazione e uso. - Google Patents

Derivati bifunzionali del polietilenglicole loro preparazione e uso.

Info

Publication number
ITPD20040159A1
ITPD20040159A1 IT000159A ITPD20040159A ITPD20040159A1 IT PD20040159 A1 ITPD20040159 A1 IT PD20040159A1 IT 000159 A IT000159 A IT 000159A IT PD20040159 A ITPD20040159 A IT PD20040159A IT PD20040159 A1 ITPD20040159 A1 IT PD20040159A1
Authority
IT
Italy
Prior art keywords
bifunctional
peg
bipeg
derivatives
pegs
Prior art date
Application number
IT000159A
Other languages
English (en)
Inventor
Gian Maria Bonora
Pietro Campaner
Sara Drioli
Original Assignee
Univ Degli Studi Trieste
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Degli Studi Trieste filed Critical Univ Degli Studi Trieste
Priority to IT000159A priority Critical patent/ITPD20040159A1/it
Publication of ITPD20040159A1 publication Critical patent/ITPD20040159A1/it
Priority to DE602005004154T priority patent/DE602005004154T2/de
Priority to US11/570,926 priority patent/US20080280998A1/en
Priority to AT05771854T priority patent/ATE382371T1/de
Priority to EP05771854A priority patent/EP1776143B1/en
Priority to PCT/EP2005/052876 priority patent/WO2005123139A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32Polymers modified by chemical after-treatment
    • C08G65/329Polymers modified by chemical after-treatment with organic compounds
    • C08G65/333Polymers modified by chemical after-treatment with organic compounds containing nitrogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00Polymeric products of isocyanates or isothiocyanates
    • C08G18/06Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/28Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
    • C08G18/40High-molecular-weight compounds
    • C08G18/48Polyethers
    • C08G18/4833Polyethers containing oxyethylene units
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00Polymeric products of isocyanates or isothiocyanates
    • C08G18/06Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/70Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the isocyanates or isothiocyanates used
    • C08G18/71Monoisocyanates or monoisothiocyanates
    • C08G18/714Monoisocyanates or monoisothiocyanates containing nitrogen in addition to isocyanate or isothiocyanate nitrogen
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32Polymers modified by chemical after-treatment
    • C08G65/329Polymers modified by chemical after-treatment with organic compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Polyethers (AREA)
IT000159A 2004-06-21 2004-06-21 Derivati bifunzionali del polietilenglicole loro preparazione e uso. ITPD20040159A1 (it)

Priority Applications (6)

Application Number Priority Date Filing Date Title
IT000159A ITPD20040159A1 (it) 2004-06-21 2004-06-21 Derivati bifunzionali del polietilenglicole loro preparazione e uso.
DE602005004154T DE602005004154T2 (de) 2004-06-21 2005-06-21 Bifunktionale derivate von polyethylenglykol, ihre herstellung und verwendung
US11/570,926 US20080280998A1 (en) 2004-06-21 2005-06-21 Bifunctional Derivatives of Polyethylene Glycol, Their Preparation and Use
AT05771854T ATE382371T1 (de) 2004-06-21 2005-06-21 Bifunktionale derivate von polyethylenglykol, ihre herstellung und verwendung
EP05771854A EP1776143B1 (en) 2004-06-21 2005-06-21 Bifunctional derivatives of polyethylene glycol, their preparation and use
PCT/EP2005/052876 WO2005123139A1 (en) 2004-06-21 2005-06-21 Bifunctional derivatives of polyethylene glycol, their preparation and use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000159A ITPD20040159A1 (it) 2004-06-21 2004-06-21 Derivati bifunzionali del polietilenglicole loro preparazione e uso.

Publications (1)

Publication Number Publication Date
ITPD20040159A1 true ITPD20040159A1 (it) 2004-09-21

Family

ID=34973166

Family Applications (1)

Application Number Title Priority Date Filing Date
IT000159A ITPD20040159A1 (it) 2004-06-21 2004-06-21 Derivati bifunzionali del polietilenglicole loro preparazione e uso.

Country Status (6)

Country Link
US (1) US20080280998A1 (it)
EP (1) EP1776143B1 (it)
AT (1) ATE382371T1 (it)
DE (1) DE602005004154T2 (it)
IT (1) ITPD20040159A1 (it)
WO (1) WO2005123139A1 (it)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1807436B1 (en) * 2004-10-25 2014-06-18 Intezyne Technologies Inc. Heterobifunctional poly(ethylene glycol) and uses thereof
CA2861601A1 (en) 2006-04-27 2007-11-08 Intezyne Technologies, Inc. Poly (ethylene glycol) containing chemically disparate endgroups
EP3590588A1 (en) 2013-12-02 2020-01-08 Biocartis N.V. Extraction of circulating nucleic acids
US11725073B2 (en) 2020-12-29 2023-08-15 Hongene Biotech Corporation Compositions and methods for liquid phase oligonucleotide synthesis
US11851454B2 (en) 2021-12-30 2023-12-26 Hongene Biotech Corporation Compositions and methods for liquid phase oligonucleotide synthesis
JP2025521412A (ja) 2022-06-21 2025-07-10 ホンジーン バイオテック コーポレイション 液相オリゴヌクレオチド合成のための組成物および方法
WO2024137756A1 (en) 2022-12-23 2024-06-27 Hongene Biotech Corporation Compounds and methods for liquid phase oligonucleotide synthesis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5268454A (en) * 1991-02-08 1993-12-07 La Jolla Pharmaceutical Company Composition for inducing humoral anergy to an immunogen comprising a t cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic carrier
WO2003031066A1 (en) * 2001-10-11 2003-04-17 California Institute Of Technology Devices utilizing self-assembled gel and method of manufacture
MXPA05008785A (es) * 2003-02-19 2005-10-18 Pharmacia Corp Esteres de polietilen glicol activados.

Also Published As

Publication number Publication date
DE602005004154D1 (de) 2008-02-14
EP1776143B1 (en) 2008-01-02
ATE382371T1 (de) 2008-01-15
EP1776143A1 (en) 2007-04-25
DE602005004154T2 (de) 2008-12-18
WO2005123139A1 (en) 2005-12-29
US20080280998A1 (en) 2008-11-13

Similar Documents

Publication Publication Date Title
Pasut et al. Polymer–drug conjugation, recent achievements and general strategies
Chabre et al. Expeditive synthesis of glycodendrimer scaffolds based on versatile TRIS and mannoside derivatives
BRPI0314831B8 (pt) composições farmacêuticas e composição de lipossoma peg compreendendo um conjugado, seus métodos de produção, kit e usos terapêuticos das ditas composições
MXPA05009726A (es) Polimeros ramificados, solubles en agua y sus conjugados.
EP2279758A3 (en) Conjugates having a degradable linkage and polymeric reagents useful in preparing such conjugates
WO2004035629A8 (en) Taxanes covalently bounded to hyaluronic acid or hyaluronic acid derivatives
UA91575C2 (ru) Дендример-пег с четырьмя ветвями для коньюгирования с белками и пептидами
MX373429B (es) Conjugados polimericos del factor viii.
WO2012058255A3 (en) Star macromolecules for personal and home care
WO2013012961A3 (en) Sugar alcohol-based crosslinking reagents, macromolecules, therapeutic bioconjugates, and synthetic methods thereof
WO2006108052A3 (en) Peg and polysialic lysosomal enzyme conjugates via acid labile linkers for therapeutic targeting
CN1556828A (zh) 具有y形分支的亲水性聚合物衍生物、其制备方法、与药物分子的结合物以及包含该结合物的药物组合物
ATE478867T1 (de) Substituierte quinazolinone verbindungen
EP1874793A4 (en) DISTRIBUTION OF SIRNA BY NEUTRAL LIPID COMPOSITIONS
WO2007019331A3 (en) Conjugates of a g-csf moiety and a polymer
WO2007016380A3 (en) Cyclitol linker polymer conjugate
EP2537533A3 (en) Antitumoral bioconjugates of hyaluronic acid or its derivatives obtained by indirect chemical conjugation
ITPD20040159A1 (it) Derivati bifunzionali del polietilenglicole loro preparazione e uso.
WO2001008707A3 (de) Konjugate und verfahren zu deren herstellung sowie deren verwendung zum transport von molekülen über biologische membranen
WO2005003775A3 (en) Glycoconjugates and their use as potential vaccines against infection by shigella flexneri
WO2006050930A3 (en) Conjugates with enhanced cell uptake activity
DE602005025355D1 (de) Konjugate enthaltend gm-csf und ein polymer
WO2006084089A3 (en) Process for the preparation of polymer conjugates
WO2005123140A3 (en) Preparation of macromolecular conjugates by four-component condensation reaction
WO2009005258A3 (en) Heparin conjugates and methods